U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.4265del (p.Asn1422fs) AND Marfan syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003326063.1

Allele description [Variation Report for NM_000138.5(FBN1):c.4265del (p.Asn1422fs)]

NM_000138.5(FBN1):c.4265del (p.Asn1422fs)

Genes:
LOC126862124:CDK7 strongly-dependent group 2 enhancer GRCh37_chr15:48764566-48765765 [Gene]
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.4265del (p.Asn1422fs)
HGVS:
  • NC_000015.10:g.48472623del
  • NG_008805.2:g.178167del
  • NG_086622.1:g.355del
  • NM_000138.5:c.4265delMANE SELECT
  • NM_001406716.1:c.4265del
  • NP_000129.3:p.Asn1422Metfs
  • NP_000129.3:p.Asn1422fs
  • NP_001393645.1:p.Asn1422fs
  • LRG_778t1:c.4264del
  • LRG_778:g.178167del
  • LRG_778p1:p.Asn1422Metfs
  • NC_000015.9:g.48764820del
  • NM_000138.4:c.4264delA
  • NM_000138.4:c.4265delA
Protein change:
N1422fs
Molecular consequence:
  • NM_000138.5:c.4265del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001406716.1:c.4265del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Marfan syndrome (MFS)
Synonyms:
MARFAN SYNDROME, TYPE I; Marfan syndrome type 1; Marfan's syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007947; MedGen: C0024796; Orphanet: 284963; Orphanet: 558; OMIM: 154700

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003853458Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust
criteria provided, single submitter

(ACMG Guidelines, 2015)		Pathogenic
(Mar 23, 2023) 		de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, SCV003853458.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 9, 2023